Concepedia

Kameron V. Kilchrist

KV

Statistics

Publications

20

Citations

1.2K

H-Index

15

Active since

2013

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

VA Tennessee Valley Healthcare System

Vanderbilt Health

Kameron V. Kilchrist is an author at Vanderbilt University specializing in drug delivery, nanoparticle drug delivery, and pharmacy.

ORCID

Publications per year

2013–2020

20

Publications

20

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy

Yazhe Wang, Ying Xie, Kameron V. Kilchrist et al. · ACS Applied Materials & Interfaces · 2020 · 173 citations · Full text

, , +17

Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers

Martina Miteva, Kellye C. Kirkbride, Kameron V. Kilchrist et al. · Biomaterials · 2014 · 143 citations · Full text

, , +14

Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing

Samantha M. Sarett, Thomas A. Werfel, Linus Lee et al. · Proceedings of the National Academy of Sciences · 2017 · 130 citations · Full text

, , +17

Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol

Meredith A. Jackson, Thomas A. Werfel, Elizabeth J. Curvino et al. · ACS Nano · 2017 · 126 citations · Full text

, , +17

Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability

Kameron V. Kilchrist, Somtochukwu C. Dimobi, Meredith A. Jackson et al. · ACS Nano · 2019 · 118 citations

, , +17

1–5 of 20